| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/11/2007 | CN1997384A Treatment of neurological conditions using complement c5a receptor modulators |
| 07/11/2007 | CN1997369A Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 07/11/2007 | CN1995323A Blend fermentation method of Callicarpa dichotoma (Lour.) K.Koch. and edible fungus, product therefrom and its uses |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1994998A 4-methyl cyclopentadecanone and its uses |
| 07/11/2007 | CN1994451A Chinese medicinal composition for treating depression, its preparation method and application |
| 07/11/2007 | CN1994446A Alcohol-relieving capsule with pueravia flower and preparation method thereof |
| 07/11/2007 | CN1994440A Orally administered Chinese medicine for treating damp heat retention type insomia |
| 07/11/2007 | CN1994439A Medicament for treating epilepsy |
| 07/11/2007 | CN1994426A Preparation method and quality control method of 'Sheng Mai' soft capsule |
| 07/11/2007 | CN1994423A Orally administered Chinese medicine for treating insomnia caused by deficiency of bladder-qi |
| 07/11/2007 | CN1994422A Orally administered Chinese medicine for treating insomnia caused by blood deficiency and endogenous heat |
| 07/11/2007 | CN1994408A Orally administered Chinese medicine for treating insomnia |
| 07/11/2007 | CN1994402A Orally administered Chinese medicine for treating insomnia caused by failure of stomach-qi to descend |
| 07/11/2007 | CN1994381A Orally administered Chinese medicinal composition for treating headache |
| 07/11/2007 | CN1994309A Use of caryophyllene compound composition in medicine for treating general anxiety neurosis and depression |
| 07/11/2007 | CN1994298A Carbamate aspartic acid specific cysteine proteinase inhibitors and uses thereof |
| 07/11/2007 | CN1994159A Kidney-strengthening mind-refreshing tobacco liquid for electronic atomized cigarette |
| 07/11/2007 | CN1994147A Health tea prepared from gastrodia tuber |
| 07/11/2007 | CN1325637C Ependymal neural stem cells and method for their isolation |
| 07/11/2007 | CN1325514C Scorpion pain-stopping anti-tumor Val-Arg-Gly peptide and its preparation method |
| 07/11/2007 | CN1325501C Heterocyclic compounds |
| 07/11/2007 | CN1325500C Furyl compounds |
| 07/11/2007 | CN1325499C Thienyl compounds |
| 07/11/2007 | CN1325498C Novel crystalline compound |
| 07/11/2007 | CN1325493C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 07/11/2007 | CN1325489C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325465C High purity (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof, preparation and the me |
| 07/11/2007 | CN1325087C Chinese medicine preparation for sobering up and liver protection |
| 07/11/2007 | CN1325055C Application of stevioside R1 and its derivative as medicine for preventing and treating neurodegeneration disease |
| 07/11/2007 | CN1325052C Benzothiazole derivatives |
| 07/11/2007 | CN1324975C Health sobering-up tea and its making method |
| 07/10/2007 | US7241887 3-azabicyclo[3.2.1]octane derivatives |
| 07/10/2007 | US7241886 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b, f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b, f/azepine-5-carboxamide |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241793 For therapy of cardiovascular diseases |
| 07/10/2007 | US7241791 Substituted 4-(indazol-3-yl)phenols |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241772 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241764 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 07/10/2007 | US7241762 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 07/10/2007 | US7241760 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241737 Urotensin-II agonists and antagonists |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | US7241460 Strontium compound for treatment of sub-dermal soft tissue pain |
| 07/10/2007 | CA2427815C Controlled release hydrocodone formulations |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2378628C New indenoindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/10/2007 | CA2135710C Melatonin derivatives for use in treating desynchronization disorders |
| 07/10/2007 | CA2124769C Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/05/2007 | WO2007076336A1 Treatment of migraine with anti-cgrp antibodies |
| 07/05/2007 | WO2007075841A1 Omega 3 fatty acid formulations |
| 07/05/2007 | WO2007075834A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy |
| 07/05/2007 | WO2007075751A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| 07/05/2007 | WO2007075717A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 07/05/2007 | WO2007075698A2 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 07/05/2007 | WO2007075695A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 07/05/2007 | WO2007075095A1 Process for the preparation of pramipexole base and/or its salts |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074786A1 Probe for diagnosis of conformational disease |
| 07/05/2007 | WO2007074346A2 Modulation of wnt signalling pathways for treating nervous system disorders |
| 07/05/2007 | WO2007074089A1 Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives |
| 07/05/2007 | WO2007073782A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | WO2007073687A1 A g protein-coupled receptor antagonist and its use for preventing and treating alzheimer’s disease |
| 07/05/2007 | WO2007073661A1 Activated collagen scaffold materials and their special fused active restoration factors |
| 07/05/2007 | WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 07/05/2007 | WO2007058583A3 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 07/05/2007 | WO2007047881A3 Method for treating neuropathic pain |
| 07/05/2007 | WO2007039869A3 Use of neboglamine in the treatment of toxicodependency |
| 07/05/2007 | WO2007039256A3 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 07/05/2007 | WO2007038058A3 Amino-aza-adamantane derivatives and methods of use |
| 07/05/2007 | WO2007026254A3 Benzodiazepine derivatives , their preparation and the therapeutic use thereof |
| 07/05/2007 | WO2006080549A3 Method and composition for treating central nervous system disorders |
| 07/05/2007 | WO2004043226A3 Methods for predicting whether subjects with mild cognitive impairment (mci) will develop alzheimer's disease |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155789 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 07/05/2007 | US20070155783 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 07/05/2007 | US20070155771 Methods and means for treating protein conformational disorders |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155740 1-(1H-Pyrazin-2-on-3-yl)-tetrahydroquinolines or tetrahydro-1,4-benzoxazines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); affective disorder, anxiety and depression |
| 07/05/2007 | US20070155735 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
| 07/05/2007 | US20070155678 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155668 Peptides modulating the activity of the engrailed transcription factor |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | DE10334188B4 Verwendung von Rotigotin zur Behandlung von Depressionen Use of rotigotine for treatment of depression |